D094609/02
Commission Implementing Regulation (EU) 2024/836 of 12 March 2024 approving the basic substance magnesium hydroxide E528 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011
Verði gerð tekin upp í EES-samninginn birtist hún hér á íslensku eftir birtingu í EES-viðbæti
D094047/03
Commission Implementing Regulation (EU) 2024/835 of 12 March 2024 renewing the approval of the active substance trinexapac, as trinexapac-ethyl, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011
Verði gerð tekin upp í EES-samninginn birtist hún hér á íslensku eftir birtingu í EES-viðbæti
D094303/03
Commission Implementing Regulation (EU) 2024/839 of 8 March 2024 renewing the approval of the low-risk active substance urea in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011
Verði gerð tekin upp í EES-samninginn birtist hún hér á íslensku eftir birtingu í EES-viðbæti
D094185/03
Commission Implementing Regulation (EU) 2024/821 of 8 March 2024 renewing the approval of the low-risk active substance hydrolysed proteins in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011
Verði gerð tekin upp í EES-samninginn birtist hún hér á íslensku eftir birtingu í EES-viðbæti
D094983/01
Commission Implementing Decision (EU) 2024/732 of 28 February 2024 postponing the expiry date of the approval of aluminium phosphide for use in biocidal products of product-types 14 and 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Verði gerð tekin upp í EES-samninginn birtist hún hér á íslensku eftir birtingu í EES-viðbæti
D094022/02
Commission Implementing Decision (EU) 2024/731 of 28 February 2024 postponing the expiry date of the approval of indoxacarb for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Verði gerð tekin upp í EES-samninginn birtist hún hér á íslensku eftir birtingu í EES-viðbæti
D094984/01
Commission Implementing Decision (EU) 2024/787 of 28 February 2024 postponing the expiry date of the approval of magnesium phosphide for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Verði gerð tekin upp í EES-samninginn birtist hún hér á íslensku eftir birtingu í EES-viðbæti
D094927/01
Commission Implementing Decision (EU) 2024/734 of 27 February 2024 postponing the expiry date of the approval of brodifacoum, bromadiolone, chlorophacinone, coumatetralyl, difenacoum, difethialone and flocoumafen for use in biocidal products of product-type 14 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Verði gerð tekin upp í EES-samninginn birtist hún hér á íslensku eftir birtingu í EES-viðbæti
D094023/02
Commission Implementing Decision (EU) 2024/733 of 28 February 2024 postponing the expiry date of the approval of cholecalciferol for use in biocidal products of product-type 14 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Verði gerð tekin upp í EES-samninginn birtist hún hér á íslensku eftir birtingu í EES-viðbæti
D094026/02
Commission Implementing Decision (EU) 2024/816 of 5 March 2024 addressing questions regarding the second comparative assessment of anticoagulant rodenticide biocidal products in accordance with Article 23(5) of Regulation (EU) No 528/2012 of the European Parliament and of the Council
Verði gerð tekin upp í EES-samninginn birtist hún hér á íslensku eftir birtingu í EES-viðbæti
D093831/02
Commission Implementing Regulation (EU) 2024/324 of 19 January 2024 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benzovindiflupyr, bromuconazole, buprofezin, cyflufenamid, fluazinam, fluopyram, flutolanil, lambda-cyhalothrin, mecoprop-P, mepiquat, metsulfuron-methyl, phosphane and pyraclostrobin
Verði gerð tekin upp í EES-samninginn birtist hún hér á íslensku eftir birtingu í EES-viðbæti
D090985/04
Commission Implementing Regulation (EU) 2024/425 of 2 February 2024 concerning the non-approval of the active substance asulam-sodium, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council
Verði gerð tekin upp í EES-samninginn birtist hún hér á íslensku eftir birtingu í EES-viðbæti
D093512/01
Commission Implementing Regulation (EU) 2024/247 of 16 January 2024 approving trihydrogen pentapotassium di(peroxomonosulfate) di(sulfate) as an existing active substance for use in biocidal products of product-types 2, 3, 4 and 5 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Verði gerð tekin upp í EES-samninginn birtist hún hér á íslensku eftir birtingu í EES-viðbæti
D093516/01
Commission Implementing Decision (EU) 2024/222 of 12 January 2024 postponing the expiry date of the approval of boric acid for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Verði gerð tekin upp í EES-samninginn birtist hún hér á íslensku eftir birtingu í EES-viðbæti
D093511/01
Commission Implementing Regulation (EU) 2024/235 of 15 January 2024 approving Alkyl (C12-16) dimethylbenzyl ammonium chloride (ADBAC/BKC (C12-C16)) as an existing active substance for use in biocidal products of product-type 2 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Verði gerð tekin upp í EES-samninginn birtist hún hér á íslensku eftir birtingu í EES-viðbæti
D093517/01
Commission Implementing Decision (EU) 2024/208 of 10 January 2024 postponing the expiry date of the approval of disodium tetraborate for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Verði gerð tekin upp í EES-samninginn birtist hún hér á íslensku eftir birtingu í EES-viðbæti
D093515/01
Commission Implementing Decision (EU) 2024/241 of 15 January 2024 not approving Willaertia magna c2c maky as an active substance for use in biocidal products of product-type 11 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Verði gerð tekin upp í EES-samninginn birtist hún hér á íslensku eftir birtingu í EES-viðbæti
D093513/01
Commission Implementing Regulation (EU) 2024/893 of 22 March 2024 approving thermally treated garlic juice as an existing active substance for use in biocidal products of product-type 19 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Verði gerð tekin upp í EES-samninginn birtist hún hér á íslensku eftir birtingu í EES-viðbæti
Commission Implementing Regulation (EU) 2023/2660 of 28 November 2023 renewing the approval of the active substance glyphosate in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) No 540/2011
Verði gerð tekin upp í EES-samninginn birtist hún hér á íslensku eftir birtingu í EES-viðbæti
Commission Implementing Decision (EU) 2023/2619 of 24 November 2023 postponing the expiry date of the approval of hydrochloric acid for use in biocidal products of product-type 2 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Verði gerð tekin upp í EES-samninginn birtist hún hér á íslensku eftir birtingu í EES-viðbæti